Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors

被引:3
|
作者
Hassan, Haitham [1 ]
Chiavaralli, Jeanne [2 ]
Hassan, Afnan [3 ,4 ]
Bedda, Loay [3 ,4 ]
Krischuns, Tim [5 ]
Chen, Kuang-Yu [5 ]
Li, Alice Shi Ming [6 ]
Delpal, Adrien [7 ]
Decroly, Etienne [7 ]
Vedadi, Masoud [6 ,8 ]
Naffakh, Nadia [5 ]
Agou, Fabrice [2 ]
Mallart, Sergio [1 ]
Arafa, Reem K. [3 ,4 ]
Arimondo, Paola B. [1 ]
机构
[1] Univ Paris Cite, Inst Pasteur, Dept Struct Biol & Chem, CNRS,UMR 3523,Chem4Life,Epigenet Chem Biol, F-75015 Paris, France
[2] Univ Paris Cite, Inst Pasteur, Ctr Technol Resources & Res C2RT, CNRS,UMR 3523,Chem4Life,Chemogen & Biol Screening, F-75015 Paris, France
[3] Drug Design & Discovery Lab, Zewail City Sci & Technol, Cairo 12578, Egypt
[4] Univ Sci & Technol, Biomed Sci Program, Zewail City Sci & Technol, Cairo 12578, Egypt
[5] Univ Paris Cite, Inst Pasteur, Unit Biol ARN & Virus Influenza, CNRS,UMR3569, F-75015 Paris, France
[6] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
[7] Marseille Univ, CNRS, UMR7257, AFMB Aix, Marseille, France
[8] QBI COVID 19 Res Grp QCRG, San Francisco, CA USA
来源
RSC MEDICINAL CHEMISTRY | 2023年 / 14卷 / 03期
关键词
D O I
10.1039/d2md00149g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A naturally inspired chemical library of 25 molecules was synthesised guided by 3-D dimensionality and natural product likeness factors to explore a new chemical space. The synthesised chemical library, consisting of fused-bridged dodecahydro-2a,6-epoxyazepino[3,4,5-c,d]indole skeletons, followed lead likeness factors in terms of molecular weight, C-sp(3) fraction and Clog P. Screening of the 25 compounds against lung cells infected with SARS-CoV-2 led to the identification of 2 hits. Although the chemical library showed cytotoxicity, the two hits (3b, 9e) showed the highest antiviral activity (EC50 values of 3.7 and 1.4 mu M, respectively) with an acceptable cytotoxicity difference. Computational analysis based on docking and molecular dynamics simulations against main protein targets in SARS-CoV-2 (main protease M-pro, nucleocapsid phosphoprotein, non-structural protein nsp10-nsp16 complex and RBD/ACE2 complex) were performed. The computational analysis proposed the possible binding targets to be either M-pro or the nsp10-nsp16 complex. Biological assays were performed to confirm this proposition. A cell-based assay for M-pro protease activity using a reverse-nanoluciferase (Rev-Nluc) reporter confirmed that 3b targets M-pro. These results open the way towards further hit-to-lead optimisations.
引用
收藏
页码:507 / 519
页数:13
相关论文
共 50 条
  • [21] Peptide-Based Inhibitors for SARS-CoV-2 and SARS-CoV
    Panchal, Disha
    Kataria, Jeena
    Patel, Kamiya
    Crowe, Kaytlyn
    Pai, Varun
    Azizogli, Abdul-Rahman
    Kadian, Neil
    Sanyal, Sreya
    Roy, Abhishek
    Dodd-o, Joseph
    Acevedo-Jake, Amanda M.
    Kumar, Vivek A.
    ADVANCED THERAPEUTICS, 2021, 4 (10)
  • [22] Design, synthesis, docking, and biochemical characterization of non-nucleoside SARS-CoV-2 RdRp inhibitors
    Brindani, Nicoletta
    Munaf, Federico
    Menichetti, Andrea
    Donati, Elisa
    Nigro, Michela
    Ottonello, Giuliana
    Armirotti, Andrea
    De Vivo, Marco
    BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 80
  • [23] Design and synthesis of isatin derivatives as effective SARS-CoV-2 3CL protease inhibitors
    Bao, Hong-Lei
    Tu, Gao
    Yue, Qiu
    Liu, Pei
    Zheng, Hui-Li
    Yao, Xiao-Jun
    CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 102 (04) : 857 - 869
  • [24] Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 Mpro Inhibitors
    Fassi, Enrico M. A.
    Manenti, Marco
    Citarella, Andrea
    Dei Cas, Michele
    Casati, Sara
    Micale, Nicola
    Schirmeister, Tanja
    Roda, Gabriella
    Silvani, Alessandra
    Grazioso, Giovanni
    MOLECULES, 2023, 28 (05):
  • [25] Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors
    Stille, Julia K. K.
    Tjutrins, Jevgenijs
    Wang, Guanyu
    Venegas, Felipe A. A.
    Hennecker, Christopher
    Rueda, Andres M.
    Sharon, Itai
    Blaine, Nicole
    Miron, Caitlin E.
    Pinus, Sharon
    Labarre, Anne
    Plescia, Jessica
    Patrascu, Mihai Burai
    Zhang, Xiaocong
    Wahba, Alexander S.
    Vlaho, Danielle
    Huot, Mitchell J.
    Schmeing, T. Martin
    Mittermaier, Anthony K. K.
    Moitessier, Nicolas
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 229
  • [26] Rational Design Problematics of Peptide Nucleic Acids as SARS-CoV-2 Inhibitors
    Grigoreva, Tatyana A.
    Vorona, Svetlana V.
    Novikova, Daria S.
    Tribulovich, Vyacheslav G.
    ACS OMEGA, 2024, 9 (30): : 33000 - 33010
  • [27] Design of novel and highly selective SARS-CoV-2 main protease inhibitors
    Poli, Adi N. R.
    Tietjen, Ian
    Nandwana, Nitesh K.
    Cassel, Joel
    Messick, Troy E.
    Register, Emery T.
    Keeney, Frederick
    Rajaiah, Rajesh
    Verma, Atul K.
    Pandey, Kabita
    Acharya, Arpan
    Byrareddy, Siddappa N.
    Montaner, Luis J.
    Salvino, Joseph M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (10)
  • [28] AI-Accelerated Design of Targeted Covalent Inhibitors for SARS-CoV-2
    Joshi, Rajendra P.
    Schultz, Katherine J.
    Wilson, Jesse William
    Kruel, Agustin
    Varikoti, Rohith Anand
    Kombala, Chathuri J.
    Kneller, Daniel W.
    Galanie, Stephanie
    Phillips, Gwyndalyn
    Zhang, Qiu
    Coates, Leighton
    Parvathareddy, Jyothi
    Surendranathan, Surekha
    Kong, Ying
    Clyde, Austin
    Ramanathan, Arvind
    Jonsson, Colleen B.
    Brandvold, Kristoffer R.
    Zhou, Mowei
    Head, Martha S.
    Kovalevsky, Andrey
    Kumar, Neeraj
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (05) : 1438 - 1453
  • [29] De Novo design of potential inhibitors against SARS-CoV-2 Mpro
    Li, Shimeng
    Wang, Lianxin
    Meng, Jinhui
    Zhao, Qi
    Zhang, Li
    Liu, Hongsheng
    COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 147
  • [30] Targetable domains for the design of peptide-dendrimer inhibitors of SARS-CoV-2
    Bellavita, Rosa
    Esposito, Speranza
    Braccia, Simone
    Madrid, Laura
    Ortega, Paula
    D'Auria, Gabriella
    Zarrilli, Federica
    Amato, Felice
    Galdiero, Stefania
    de la Mata, Javier
    Falcigno, Lucia
    Falanga, Annarita
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 661